Virginia STEM News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Virginia STEM News.

Press releases published on November 5, 2026

Nov. 5, 2026

SINTX Reports Record Third Quarter 2026 Revenue Growth and Advances Medical Device Commercialization

Indeterminate GlobeNewswire

Nov. 5, 2026

Rakovina Therapeutics Announces Shares for Debt Transaction

Indeterminate GlobeNewswire

Nov. 5, 2026

vTv Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 5, 2026

Keros Therapeutics Reports Recent Business Highlights and Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Voyager Reports Third Quarter 2026 Financial and Operating Results

Indeterminate GlobeNewswire

Nov. 5, 2026

aTyr Pharma Announces Third Quarter 2026 Results and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 5, 2026

Celldex Reports Third Quarter Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 5, 2026

Biodesix Announces Third Quarter 2026 Results and Highlights

Indeterminate GlobeNewswire

Nov. 5, 2026

Eton Pharmaceuticals Announces Preliminary ET-700 Pilot Study Results Evaluating Copper Absorption Inhibition and Gastrointestinal Tolerability

Indeterminate GlobeNewswire

Nov. 5, 2026

Ascendis to Report Third Quarter 2026 Financial Results and Provide Business Update on November 12, 2026

Indeterminate GlobeNewswire

Nov. 5, 2026

Elicio Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 5, 2026

IN8bio Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Nov. 5, 2026

Tectonic Therapeutic Announces Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

Nov. 5, 2026

Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

ARS Pharma Reports Business Highlights and Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 5, 2026

Turtle Beach Corporation Announces Third Quarter 2026 Results and Reaffirms Full Year Guidance

Indeterminate GlobeNewswire

Nov. 5, 2026

Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Nov. 5, 2026

Orchestra BioMed Announces Proposed Public Offering

Indeterminate GlobeNewswire

Nov. 5, 2026

INmune Bio Inc. Announces Third Quarter 2026 Results and Provides Business Update

Indeterminate GlobeNewswire